News

Limited benefits for osteoarthritis patients from acetaminophen


 

References

Acetaminophen is ineffective for short-term treatment of low back pain and has limited benefit for patients with knee or hip osteoarthritis, according to a systematic review of randomized, controlled trials by Gustavo Machado and his associates.

In three trials, there was no significant difference between acetaminophen and a placebo on pain relief for people with low back pain. In 10 trials involving patients with hip or knee osteoarthritis, acetaminophen provided a statistically significant benefit over placebo, but the effect was small. There were similar rates of adverse side effects, medication adherence, and use of rescue medication in both groups.

The review also “found higher risk of abnormal results on liver function tests in patients taking [acetaminophen], though the clinical implications of this are uncertain,” the investigators said.

Find the full review in the BMJ (doi:10.1136/bmj.h1225).

Recommended Reading

CDC: Opioid use high among reproductive age women
MDedge Rheumatology
Opioid abuse major concern for primary care physicians
MDedge Rheumatology
Abuse-deterrent formulation of extended-release hydrocodone approved
MDedge Rheumatology
New fatigue diagnosis is a valid disease
MDedge Rheumatology
How to halt ‘a heart attack of the finger’
MDedge Rheumatology
VIDEO: Ask patients about metal-on-metal hip implants
MDedge Rheumatology
VIDEO: Homeopathic injectables topped placebo for knee osteoarthritis
MDedge Rheumatology
Newly isolated spider venom compounds could relieve chronic pain
MDedge Rheumatology
Stepped-care intervention beats usual care in veterans with chronic pain
MDedge Rheumatology
Overall physical health strongly predicts arthritis pain
MDedge Rheumatology